GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Pretax Margin %

Biovica International AB (OSTO:BIOVIC B) Pretax Margin % : -2,566.05% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biovica International AB's Pre-Tax Income for the three months ended in Jan. 2024 was kr-27.59 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Therefore, Biovica International AB's pretax margin for the quarter that ended in Jan. 2024 was -2,566.05%.

The historical rank and industry rank for Biovica International AB's Pretax Margin % or its related term are showing as below:

OSTO:BIOVIC B' s Pretax Margin % Range Over the Past 10 Years
Min: -3270.69   Med: -1810.83   Max: -245.27
Current: -1899.51


OSTO:BIOVIC B's Pretax Margin % is ranked worse than
80.06% of 1018 companies
in the Biotechnology industry
Industry Median: -154.275 vs OSTO:BIOVIC B: -1899.51

Biovica International AB Pretax Margin % Historical Data

The historical data trend for Biovica International AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Pretax Margin % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only -716.27 -1,810.83 -1,896.29 -2,933.55 -3,270.69

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,151.19 -3,907.88 -1,821.27 -927.51 -2,566.05

Competitive Comparison of Biovica International AB's Pretax Margin %

For the Biotechnology subindustry, Biovica International AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Pretax Margin % falls into.



Biovica International AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Biovica International AB's Pretax Margin for the fiscal year that ended in Apr. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=-110.68/3.384
=-3,270.69 %

Biovica International AB's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-27.585/1.075
=-2,566.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Biovica International AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines